Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renaud Felten

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
RMD Open|August 14, 2025
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyNan Shen, Julia Weinmann-Menke, Ana Malvar, et al.
RMD Open|August 29, 2024
Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's diseaseRenaud Felten, Anne-Perrine Foray, Pascal Schneider, et al.
Seminars in Arthritis and Rheumatism|September 13, 2020
Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case seriesHervé Lobbes, Charles Dervout, Eric Toussirot, et al.
Journal of Clinical Medicine|April 13, 2024
Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR CohortRenaud Felten, Thibaut Fabacher, Nathanaël Sedmak, et al.
Rheumatology (Oxford, England)|March 4, 2023
Identification of new candidate drugs for primary Sjögren's syndrome using a drug repurposing transcriptomic approachRenaud Felten, Tao Ye, Cedric Schleiss, et al.
BMC Medical Education|August 30, 2025
Advancing medical training with augmented reality and haptic feedback simulator: outcomes of a randomized controlled trial on lumbar punctureRenaud Felten, Kevin Bigaut, Thomas Wirth, et al.
Lupus Science & Medicine|February 8, 2019
10 most important contemporary challenges in the management of SLERenaud Felten, Flora Sagez, Pierre-Edouard Gavand, et al.
Rheumatology International|September 30, 2022
How to optimize recruitment strategies of patients with rheumatic and musculoskeletal diseases for online surveys: experience from an international studyIhsane Hmamouchi, Antonella Abi Najm, Lina El Kibbi, et al.
The Lancet. Rheumatology|January 22, 2024
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trialAlain Saraux, Catherine Le Henaff, Emmanuelle Dernis, et al.
Arthritis Research & Therapy|July 14, 2021
Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in FranceRenaud Felten, Marc Scherlinger, Aurélien Guffroy, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
RMD Open|August 14, 2025
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyNan Shen, Julia Weinmann-Menke, Ana Malvar, et al.
RMD Open|August 29, 2024
Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's diseaseRenaud Felten, Anne-Perrine Foray, Pascal Schneider, et al.
Seminars in Arthritis and Rheumatism|September 13, 2020
Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case seriesHervé Lobbes, Charles Dervout, Eric Toussirot, et al.
Journal of Clinical Medicine|April 13, 2024
Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR CohortRenaud Felten, Thibaut Fabacher, Nathanaël Sedmak, et al.
Rheumatology (Oxford, England)|March 4, 2023
Identification of new candidate drugs for primary Sjögren's syndrome using a drug repurposing transcriptomic approachRenaud Felten, Tao Ye, Cedric Schleiss, et al.
BMC Medical Education|August 30, 2025
Advancing medical training with augmented reality and haptic feedback simulator: outcomes of a randomized controlled trial on lumbar punctureRenaud Felten, Kevin Bigaut, Thomas Wirth, et al.
Lupus Science & Medicine|February 8, 2019
10 most important contemporary challenges in the management of SLERenaud Felten, Flora Sagez, Pierre-Edouard Gavand, et al.
Rheumatology International|September 30, 2022
How to optimize recruitment strategies of patients with rheumatic and musculoskeletal diseases for online surveys: experience from an international studyIhsane Hmamouchi, Antonella Abi Najm, Lina El Kibbi, et al.
The Lancet. Rheumatology|January 22, 2024
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trialAlain Saraux, Catherine Le Henaff, Emmanuelle Dernis, et al.
Arthritis Research & Therapy|July 14, 2021
Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in FranceRenaud Felten, Marc Scherlinger, Aurélien Guffroy, et al.
Pageof 7